Rouette, Julie
Yin, Hui
Pottegård, Anton
Nirantharakumar, Krishnarajah
Azoulay, Laurent http://orcid.org/0000-0001-5162-3556
Funding for this research was provided by:
Canadian Institutes of Health Research (FDN-143328)
Article History
Accepted: 14 October 2020
First Online: 26 October 2020
Declarations
:
: This work was supported by a Foundation Scheme grant from the Canadian Institutes of Health Research (FDN-143328). JR is the recipient of a Doctoral Award from the Canadian Institutes of Health Research (FRN-152254). LA holds a Chercheur-Boursier Senior Award from the Fonds de Recherche du Québec—Santé and is the recipient of a William Dawson Scholar award from McGill University. Researchers were independent from the funding sources. The funding sources had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: JR received consulting fees for work unrelated to this project from Biogen. LA received consulting fees from Janssen and Pfizer for work unrelated to this paper. AP reports participation in research projects funded by Alcon, Almirall Astellas, AstraZeneca, Boehringer-Ingelheim, Novo Nordisk, Servier and LEO Pharma, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the work reported in this paper. KN received research funding from AstraZeneca, Vifor and CSL Behring and personal fees from MSD, Sanofi and Boehringer Ingelheim, all unrelated to this study. HY has no conflicts of interest to disclose.
: The study protocol was approved by the Independent Scientific Advisory Committee of the CPRD (protocol number 19_279A) and the Research Ethics Board of the Jewish General Hospital, Montreal, Canada (number 2020-2207).
: Not applicable.
: Not applicable.
: The data cannot be shared publicly due to patients’ privacy, as per the Clinical Practice Research Datalink policy.
: The codes cannot be shared publicly, as per the Lady Davis Institute—Centre for Clinical Epidemiology policy.
: Conception and planning of the work that led to the manuscript (JR, HY, LA). Acquisition, analysis and interpretation of the data (JR, HY, AP, KN, LA). Drafting and/or critical revision of the manuscript for important intellectual content (JR, HY, AP, KN, LA). Approval of the final submitted version of the manuscript (JR, HY, AP, KN, LA).